CR10003A - Prodrogas de sulfonato de sulfamoilo - Google Patents

Prodrogas de sulfonato de sulfamoilo

Info

Publication number
CR10003A
CR10003A CR10003A CR10003A CR10003A CR 10003 A CR10003 A CR 10003A CR 10003 A CR10003 A CR 10003A CR 10003 A CR10003 A CR 10003A CR 10003 A CR10003 A CR 10003A
Authority
CR
Costa Rica
Prior art keywords
sulfamoil
production
sulfonate products
sulfonate
products
Prior art date
Application number
CR10003A
Other languages
English (en)
Inventor
Ralf Wyrwa
Reinhard Nubbemeyer
Ursula Ganzer
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CR10003A publication Critical patent/CR10003A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Esta invención se relaciona con prodrogas de sulfonato de sulfamoilo de fórmula general I, con un proceso para su producción, con composiciones farmacéuticas que contienen estos compuestos, y con su uso para la producción de agentes farmacéuticos disponibles por vía oral. Los compuestos de acuerdo a la invención se unen a anhidrasas carbónicas e inhiben a estas enzimas.
CR10003A 2005-11-30 2008-05-21 Prodrogas de sulfonato de sulfamoilo CR10003A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005057408A DE102005057408A1 (de) 2005-11-30 2005-11-30 Sulfamoylsulfonat-Prodrugs

Publications (1)

Publication Number Publication Date
CR10003A true CR10003A (es) 2008-08-21

Family

ID=37983623

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10003A CR10003A (es) 2005-11-30 2008-05-21 Prodrogas de sulfonato de sulfamoilo

Country Status (15)

Country Link
EP (1) EP1957513A2 (es)
JP (1) JP2009517424A (es)
KR (1) KR20080072956A (es)
CN (1) CN101316858A (es)
AU (1) AU2006319380A1 (es)
BR (1) BRPI0619253A2 (es)
CA (1) CA2632272A1 (es)
CR (1) CR10003A (es)
DE (1) DE102005057408A1 (es)
EA (1) EA200801306A1 (es)
EC (1) ECSP088489A (es)
IL (1) IL191570A0 (es)
NO (1) NO20082915L (es)
WO (1) WO2007062874A2 (es)
ZA (1) ZA200805659B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010110747A1 (en) * 2009-03-24 2010-09-30 National University Of Singapore Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (copd)
CN101987104A (zh) * 2009-08-05 2011-03-23 天津金耀集团有限公司 一种杂芳香基氨磺酰基羧酸酯碳酸酐酶抑制剂的眼用组合物
CN101987101A (zh) * 2009-08-05 2011-03-23 天津金耀集团有限公司 糖皮质激素芳香基氨磺酰基磺酸酯为活性成分的眼用抗炎组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102004025985A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estriol- und Estetrol-Prodrugs
DE102004025986A1 (de) * 2004-05-21 2005-12-15 Schering Ag Steroid-Prodrugs mit androgener Wirkung
DE102004025966A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estradiol-Prodrugs

Also Published As

Publication number Publication date
JP2009517424A (ja) 2009-04-30
WO2007062874A2 (de) 2007-06-07
EA200801306A1 (ru) 2008-10-30
EP1957513A2 (de) 2008-08-20
WO2007062874B1 (de) 2007-09-27
NO20082915L (no) 2008-06-27
ECSP088489A (es) 2008-06-30
AU2006319380A1 (en) 2007-06-07
DE102005057408A1 (de) 2007-05-31
CA2632272A1 (en) 2007-06-07
BRPI0619253A2 (pt) 2011-09-27
IL191570A0 (en) 2008-12-29
ZA200805659B (en) 2009-10-28
KR20080072956A (ko) 2008-08-07
CN101316858A (zh) 2008-12-03
WO2007062874A3 (de) 2007-07-12

Similar Documents

Publication Publication Date Title
PA8693101A1 (es) Compuestos de isoindol-imida y composiciones que los incluyen y mètodos para su uso
UY28747A1 (es) Nuevo proceso para la sintesis y nueva forma cristalina de agomelatina y composiciones farmaceuticas que las contienen
ECSP099044A (es) Compuestos de pirimido fusionados
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
CR11618A (es) Inhibidores macrocíclicos de serina proteasa
CU20090070A7 (es) Nuevos derivados de sulfonamida como antagonistas de la bradiquinina
UY29530A1 (es) Compuestos quimicos
CR10479A (es) Modulares bencimidazolicos de vr1
UY29479A1 (es) Inhibidores de adn-pk
UY30025A1 (es) Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones.
CR10696A (es) Compuestos de n-metilaminometil isoindol, composiciones que las comprenden y metodos que utilizan los mismos
GT200500296A (es) Sintesis asimetrica de derivados del dehidrobenzofurano
PA8796201A1 (es) Agentes anti-infecciosos y su uso
CR8753A (es) Derivados de tetraazabenzo [e] azuleno y sus analogos
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
UY30748A1 (es) Compuesto0s novedosos
AR058348A1 (es) Derivados de 1-aza-biciclo-nonano y composiciones farmaceuticas que los comprenden
UY29607A1 (es) Compuestos quimicos
CR9507A (es) Sulfonamidas de diarisulfona y sus usos
HN2008000088A (es) Heterociclicos de 1,4-dihidropiridina- fusionada, procesos para preparar los mismos, su uso y las composiciones que los contienen.
CR10557A (es) Bencilaminas, un proceso para la produccion y su uso como agentes antiinflamatorios
BRPI0712889A8 (pt) composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica.
ECSP099389A (es) Nuevas formas cristalinas
UY30801A1 (es) Compuestos calciliticos
GT200500382A (es) Sulfonamido-macrociclos y sus sales como inhibidores de tie2, composicion farmaceutica que comprende estos compuestos, metodo de prepararlos y su uso

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)